A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease

This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.

Podrobná bibliografie
Hlavní autor:	Haque, Mushfiqul
Další autoři:	Kabir, Md. Tanvir
Médium:	Project report
Jazyk:	English
Vydáno:	BRAC University 2019
Témata:	Alzheimer’s disease Cholinesterase inhibitors NMDA antagonists Combination therapy Efficacy Cost effectiveness
On-line přístup:	http://hdl.handle.net/10361/11070

Podobné jednotky

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Autor: Ishrat, Nowshin
Vydáno: (2024)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
Autor: Alam, Badrul, a další
Vydáno: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Flora, Sanzida Alam
Vydáno: (2024)

A review on artemisinin based combination therapy for the treatment of Malaria
Autor: Chowdhury, Amina Ferdous
Vydáno: (2020)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Autor: Alim, Abdul
Vydáno: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Autor: Meem, Manila
Vydáno: (2023)

Open source, low cost combine harvester
Autor: Sazim, Md. Abdullah Bin, a další
Vydáno: (2019)

In-vitro preformulation studies for the development of a novel antidiabetic combination therapy involving linagliptin and dextromethorphan
Autor: Shishir, Tushar Ahmed
Vydáno: (2018)

A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
Autor: Chakraborty, Anupama
Vydáno: (2024)

Identification of FAP inhibitors using in silico simulation study
Autor: Deeba, Maliha Tasnim
Vydáno: (2018)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Autor: Islam, Saidul
Vydáno: (2022)

Comparison of diabetes knowledge and self-efficacy in diabetes management among the urban people and the people from Garo tribe in Mymensingh division
Autor: Hossain, Md. Rafayat
Vydáno: (2020)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Autor: Islam, Nahidul
Vydáno: (2023)

Alzheimer's disease and marriage : an intimate account /
Autor: Wright, Lore K.
Vydáno: (1993)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Autor: Tabassum, Nadira
Vydáno: (2024)

A pragmatic approach to the analysis of a combination formulation
Autor: Mubtasim, Noshin, a další
Vydáno: (2016)

Role of protein’s and future treatment options for Alzheimer’s Disease
Autor: Islam, Md. Irfath
Vydáno: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Autor: Chowdhury, Sariya Uzrat
Vydáno: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Karim, Samia Binte
Vydáno: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Autor: Shehab, Habibul Mohsin
Vydáno: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Autor: Saha, Bithi Rani
Vydáno: (2023)

Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: disentangling the issues
Autor: Ekstrom, Eva-Charlotte, a další
Vydáno: (2019)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Autor: Afroza, Halima
Vydáno: (2024)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
Autor: Akter, Rabia
Vydáno: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Autor: Hassan, Md. Muhtaz
Vydáno: (2020)

Efficacy of sertraline in the treatment of major depressive disorder smong adult population: a systematic review
Autor: Maha, Tasfiah Tasnim
Vydáno: (2024)

Emerging therapies of Alzheimer’s disease: a comprehensive review
Autor: Tasin, Md Abtahi
Vydáno: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Autor: Aziz, Farhin
Vydáno: (2019)

Marine compounds in the treatment of Alzheimer’s disease
Autor: Parveen, Sanjana
Vydáno: (2022)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Autor: Tamanna, Mst. Taskia
Vydáno: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
Autor: Afra, Sumaiya
Vydáno: (2022)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Autor: Karim, Azrin
Vydáno: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
Autor: Oshin, Sadia Afrin
Vydáno: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Autor: Halim, Rabea
Vydáno: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Autor: Paul, Pulock
Vydáno: (2024)

An ambient assisted living system for Alzheimer’s patients
Autor: Abedin, Minhajul, a další
Vydáno: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
Autor: Rahman, Quazi Ashikur, a další
Vydáno: (2022)

Detection of alzheimer's disease using deep learning
Autor: Hasan, Mahmudul, a další
Vydáno: (2021)

A review on adult neurogenesis in Alzheimer’s disease
Autor: Akter, Moriam
Vydáno: (2022)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
Autor: Mahin, Md. Tamjidur Rahman
Vydáno: (2024)